Microbot Medical Inc 's Cash & cash equivalent grew by 80.39 % in the Q2 2026 sequentially, faster than Current Liabilities, this led to improvement in Microbot Medical Inc 's Quick Ratio to 34.1, above Microbot Medical Inc average Quick Ratio.

Within Medical Equipment & Supplies industry Microbot Medical Inc booked the highest Quick Ratio than Microbot Medical Inc in the second quarter 2026. While Quick Ratio total ranking has improved so far during the Q2 2026 to 98, from total ranking in the first quarter 2026 at 120.

Explain Quick Ratio?
How much Cash & cash equivalents MBOT�s has?
What are MBOT�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

MBOT Quick Ratio	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3	(Jun 30 2025) Q2
Y / Y Current Liabilities Change	48.11 %	69.88 %	30.75 %	101.91 %	113.24 %
Y / Y Cash & cash equivalent Change	305.16 %	141.49 %	1337.38 %	1728.82 %	402.72 %
Quick Ratio MRQ	34.1	24	25.39	30.42	12.47
MBOT's Total Ranking	# 98	# 120	# 106	# 68	# 207
Seq. Current Liabilities Change	26.93 %	-1.98 %	18.51 %	0.46 %	45.59 %
Seq. Cash & cash equivalent Change	80.39 %	-7.34 %	-1.1 %	145.09 %	7.52 %

Quick Ratio second quarter 2026 Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 1
Healthcare Sector	# 17
Overall Market	# 98

Quick Ratio Statistics
High	Average	Low
42.7	10.12	0.37
(Jun 30 2020)		(Jun 30 2016)

Financial Statements
Microbot Medical Inc 's Current Liabilities	$ 4 Millions	Visit MBOT's Balance sheet
Microbot Medical Inc 's Cash & cash equivalent	$ 133 Millions	Visit MBOT's Balance sheet
Source of MBOT's Sales		Visit MBOT's Sales by Geography

Cumulative Microbot Medical Inc 's Quick Ratio

MBOT's Quick Ratio for the trailling 12 Months

MBOT Quick Ratio	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months	(Jun 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	56.49 %	70.13 %	72.16 %	32.72 %	14.37 %
Y / Y Cash & cash equivalent TTM Growth	400.4 %	467.25 %	876.27 %	527.54 %	112.67 %
Quick Ratio TTM	28.76	23.21	21.86	15.75	8.99
Total Ranking TTM	# 2664	# 2823	# 2222	# 2018	# 2607
Seq. Current Liabilities TTM Growth	11.03 %	12.37 %	7.77 %	16.38 %	20.71 %
Seq. Cash & cash equivalent TTM Growth	37.58 %	19.34 %	49.57 %	103.77 %	55.96 %

Quick ratio ranking by company, industry and sector >> Back to MBOT Financial Strength Comparisons >> Go to Compare MBOT Quick Ratio to its Competitors

On the trailing twelve months basis MBOT Cash & cash equivalent more than doubled by 305.16 % in Q2 2026 year on year, faster than Current Liabilities, this led to increase in in Microbot Medical Inc 's Quick Ratio to 28.76, above MBOT average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 166 other companies have achieved higher Quick Ratio than Microbot Medical Inc . While Quick Ratio overall ranking has improved so far to 2664, from total ranking during the twelve months ending first quarter 2026 at 2823.

Explain Quick Ratio?
How much Cash & cash equivalents MBOT�s has?
What are MBOT�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Equipment & Supplies Industry	# 167
Healthcare Sector	# 777
Within the Market	# 2664

trailing twelve months Quick Ratio Statistics
High	Average	Low
27.04	7.93	0.79
(Dec 31 2020)		(Mar 31 2017)

Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry	Quick Ratio	Jun 30 2026 MRQ Cash & cash equivalent	Jun 30 2026 MRQ Current Liabilities
Utah Medical Products Inc	42.28	$ 87.528 Millions	$ 2.070 Millions
Microbot Medical Inc	34.10	$ 132.596 Millions	$ 3.888 Millions
Global Innovative Platforms Inc.	31.35	$ 0.244 Millions	$ 0.008 Millions
Anteris Technologies Global Corp	14.02	$ 257.385 Millions	$ 18.360 Millions
Heartflow Inc	13.95	$ 615.238 Millions	$ 44.088 Millions
Ceribell Inc	13.13	$ 225.898 Millions	$ 17.200 Millions
Perspective Therapeutics Inc	12.80	$ 467.708 Millions	$ 36.544 Millions
Lemaitre Vascular Inc	12.57	$ 376.240 Millions	$ 29.935 Millions
Mobia Medical Inc	12.24	$ 177.090 Millions	$ 14.472 Millions
Envveno Medical Corporation	11.39	$ 21.486 Millions	$ 1.887 Millions
Pulse Biosciences Inc	9.26	$ 101.620 Millions	$ 10.978 Millions
Orchestra Biomed Holdings Inc	8.16	$ 109.963 Millions	$ 13.471 Millions
Biolife Solutions Inc	8.11	$ 113.100 Millions	$ 13.947 Millions
Bone Biologics Corporation	7.87	$ 4.032 Millions	$ 0.512 Millions
Beyond Air Inc	7.68	$ 26.340 Millions	$ 3.428 Millions
Talkspace Inc	7.62	$ 90.998 Millions	$ 11.937 Millions
Safe Pro Group Inc	7.24	$ 10.231 Millions	$ 1.413 Millions
Delcath Systems Inc	7.22	$ 95.902 Millions	$ 13.279 Millions
Streamex Corp	7.16	$ 18.586 Millions	$ 2.595 Millions
Endra Life Sciences Inc	7.04	$ 5.540 Millions	$ 0.787 Millions

Date modified: 2026-09-08T18:50:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.